T. Diversité-du-répertoire, 60 D. Evaluation de la capacité fonctionnelle, p.62

L. Serum, A. Serums-anti-lymphocytaires-en, A. De, and C. , 63 I, PARTIE, vol.3, p.63

R. , I. Caracteristiques, L. De, and E. Population, 76 A. En pré-greffe, p.76

L. 'incidence-des-infections and .. , 113 1/ Facteurs explicatifs d'une infection bactérienne 113 2/ Facteurs explicatifs de la survenue d'une infection, p.115

.. Le-rejet-de-greffe, 130 2/ La maladie du greffon contre l'hôte, p.131

. En-analyse-univariée, hémopathie maligne (p=0,05 à J100 et p=0,0009 à J360) et la survenue d'une GVHc extensive (p=0,02 à J360) ralentissent la RI des LT8. Le statut sérologique positif du donneur vis-à-vis du CMV semble amélioré à J180 la reconstitution des LT8 (p=0,06) Aucun facteur de risque en analyse multivariée n'a influencé la probabilité d

. En-analyse-univariée, âge adulte (p=0,005 à J60 et p=0,001 J360), le diagnostique initial d'hémopathie maligne de type leucémie aiguë ou chronique (p=0,002 à J60), J360) et la survenue de GVHc extensive

. En-analyse-univariée, les facteurs de risque diminuant la probabilité d'atteindre un taux de LB>200/l sont : l'âge> 18 ans (p = 0,002), le conditionnement myéloablatif (p=0,06), p.6

F. Appelbaum, Haematopoietic cell transplantation as immunotherapy, Nature, vol.411, issue.6835, pp.385-394, 2001.
DOI : 10.1038/35077251

L. Welniak, B. Blazar, and W. Murphy, Immunobiology of Allogeneic Hematopoietic Stem Cell Transplantation, Annual Review of Immunology, vol.25, issue.1, pp.139-70, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141606

M. Horowitz, R. Gale, and P. Sondel, Graft-versus-leukemia reactions after bone marrow transplantation, Blood Feb, vol.175, issue.3, pp.555-62, 1990.

A. Dickinson, X. Wang, and L. Sviland, In situ dissection of the graft-versus-host activities of cytotoxic T cells specific for minor histocompatibility antigens, Nature Medicine, vol.6, issue.4, pp.410-414, 2002.
DOI : 10.1038/79573

J. Falkenburg, A. Wafelman, and P. Joosten, Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes, Blood Aug, vol.1594, issue.4, pp.1201-1209, 1999.

E. Alyea, R. Soiffer, and C. Canning, Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant, Blood, vol.91, issue.10, pp.3671-80, 1998.

M. Lisbonne and M. Leite-de-moraes, Invariant Valpha14 NKT lymphocytes: a doubleedged immuno-regulatory T cell population, Eur Cytokine Netw, vol.14, issue.1, pp.4-14, 2003.

M. Kronenberg, TOWARD AN UNDERSTANDING OF NKT CELL BIOLOGY: Progress and Paradoxes, Annual Review of Immunology, vol.23, issue.1, pp.877-900, 2005.
DOI : 10.1146/annurev.immunol.23.021704.115742

M. Leite-de-moraes, G. Moreau, and A. Arnould, IL-4-producing NK T cells are biased towards IFN-?? production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells, European Journal of Immunology, vol.103, issue.5, pp.1507-1522, 1998.
DOI : 10.1002/(SICI)1521-4141(199805)28:05<1507::AID-IMMU1507>3.0.CO;2-F

URL : http://onlinelibrary.wiley.com/doi/10.1002/(SICI)1521-4141(199805)28:05<1507::AID-IMMU1507>3.0.CO;2-F/pdf

M. Leite-de-moraes, M. Lisbonne, and A. Arnould, Ligand-activated natural killer T lymphocytes promptly produce IL-3 and GM-CSF in vivo: relevance to peripheral myeloid recruitment, European Journal of Immunology, vol.32, issue.7, pp.1897-904, 2002.
DOI : 10.1002/1521-4141(200207)32:7<1897::AID-IMMU1897>3.0.CO;2-Y

M. Lisbonne, P. Hachem, and M. Tonanny, In vivo activation of invariant V??14 natural killer T?cells by??-galactosylceramide sequentially induces Fas-dependent and -independent cytotoxicity, European Journal of Immunology, vol.34, issue.5, pp.1381-1389, 2004.
DOI : 10.1002/eji.200324828

E. Morris, K. Macdonald, and V. Rowe, NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs, Journal of Clinical Investigation, vol.115, issue.11, 2005.
DOI : 10.1172/JCI25249DS1

L. Ruggeri, M. Capanni, and E. Urbani, Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants, Science, vol.295, issue.5562, pp.2097-100, 2002.
DOI : 10.1126/science.1068440

H. Kolb, W. Guenther, and B. Gyurkocza, Tolerance and chimerism, Transplantation May, vol.1575, issue.9, pp.26-31, 2003.

H. Kolb, B. Simoes, and C. Schmid, Cellular immunotherapy after allogeneic stem cell transplantation in hematologic malignancies, Current Opinion in Oncology, vol.16, issue.2, pp.167-73, 2004.
DOI : 10.1097/00001622-200403000-00015

G. Xia, R. Truitt, and B. Johnson, Graft-versus-Leukemia and Graft-versus-Host Reactions after Donor Lymphocyte Infusion Are Initiated by Host-Type Antigen-Presenting Cells and Regulated by Regulatory T Cells in Early and Long-Term Chimeras, Biology of Blood and Marrow Transplantation, vol.12, issue.4, pp.397-407, 2006.
DOI : 10.1016/j.bbmt.2005.11.519

A. Barrett, Mechanisms of the Graft&hyphen;versus&hyphen;Leukemia Reaction, Stem Cells, vol.81, issue.4, pp.248-58, 1997.
DOI : 10.1002/stem.150248

P. Martin, G. Schoch, and L. Fisher, A retrospective analysis of therapy for acute graftversus-host disease: initial treatment National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report, Blood Biol Blood Marrow Transplant, vol.76, issue.21, pp.1464-72, 1990.

G. Vogelsang and S. Arai, Mycophenolate mofetil for the prevention and treatment of graft-versus-host disease following stem cell transplantation: preliminary findings, Bone Marrow Transplantation, vol.22, issue.12, pp.1255-62, 2001.
DOI : 10.1097/00007691-199908000-00036

W. Shlomchik, Graft-versus-host disease, Nature Reviews Immunology, vol.171, issue.5, pp.340-52, 2007.
DOI : 10.4049/jimmunol.171.3.1272

G. Hill, J. Crawford, K. Cooke, Y. Brinson, L. Pan et al., Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines, Blood, vol.90, issue.8, pp.3204-3217, 1997.

T. Kawase, Y. Morishima, and K. Matsuo, High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism Identification of a graft versus host disease-associated human minor histocompatibility antigen, Blood Science, vol.110268, issue.75216, pp.2235-411476, 1995.

H. Erlich, G. Opelz, and J. Hansen, HLA DNA Typing and Transplantation, Immunity, vol.14, issue.4, 2001.
DOI : 10.1016/S1074-7613(01)00115-7

URL : https://doi.org/10.1016/s1074-7613(01)00115-7

C. Cutler, S. Giri, S. Jeyapalan, D. Paniagua, A. Viswanathan et al., Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis, Journal of Clinical Oncology, vol.19, issue.16, pp.3685-91, 2001.
DOI : 10.1200/JCO.2001.19.16.3685

M. Laughlin, M. Eapen, and P. Rubinstein, Outcomes after Transplantation of Cord Blood or Bone Marrow from Unrelated Donors in Adults with Leukemia, New England Journal of Medicine, vol.351, issue.22, pp.2265-75, 2004.
DOI : 10.1056/NEJMoa041276

Y. Sun, I. Tawara, T. Toubai, and P. Reddy, Pathophysiology of acute graft-versus-host disease: recent advances, Translational Research, vol.150, issue.4, pp.197-214, 2007.
DOI : 10.1016/j.trsl.2007.06.003

X. Chen, S. Vodanovic-jankovic, B. Johnson, M. Keller, R. Komorowski et al., Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease, Blood, vol.110, issue.10, pp.3804-3817, 2007.
DOI : 10.1182/blood-2007-05-091074

T. Daikeler and A. Tyndall, Autoimmunity following haematopoietic stem-cell transplantation, Best Practice & Research Clinical Haematology, vol.20, issue.2, pp.349-60, 2007.
DOI : 10.1016/j.beha.2006.09.008

C. Zhang, I. Todorov, and Z. Zhang, Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations, Blood, vol.107, issue.7, pp.2993-3001, 2006.
DOI : 10.1182/blood-2005-09-3623

P. Weiden, N. Flournoy, J. Sanders, K. Sullivan, and E. Thomas, Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation, Transplant Proc, vol.13, issue.1, pp.248-51, 1981.

G. Vogelsang, L. Lee, and D. Bensen-kennedy, Pathogenesis and Treatment of Graft-Versus-Host Disease After Bone Marrow Transplant, Annual Review of Medicine, vol.54, issue.1, pp.29-52, 2003.
DOI : 10.1146/annurev.med.54.101601.152339

H. Shulman, D. Kleiner, and S. Lee, Histopathologic Diagnosis of Chronic Graft-versus-Host Disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report, Biology of Blood and Marrow Transplantation, vol.12, issue.1, pp.31-47, 2006.
DOI : 10.1016/j.bbmt.2005.10.023

H. Glucksberg, R. Storb, and A. Fefer, CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S, Transplantation, vol.18, issue.4, pp.295-304, 1974.
DOI : 10.1097/00007890-197410000-00001

H. Shulman, K. Sullivan, and P. Weiden, Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients, Am J Med, 1980.

J. Wingard, J. Hsu, and J. Hiemenz, Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology, Hematol Oncol Clin North Am, 2011.

R. Seggewiss and H. Einsele, Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update, Blood, vol.115, issue.19, pp.3861-3869, 2010.
DOI : 10.1182/blood-2009-12-234096

D. Przepiorka, T. Smith, and J. Folloder, Controlled trial of filgrastim for acceleration of neutrophil recovery after allogeneic blood stem cell transplantation from human leukocyte antigen-matched related donors, Blood, vol.97, issue.11, pp.3405-3415, 2001.
DOI : 10.1182/blood.V97.11.3405

M. Mohty, Allogeneic hematopoietic stem cell transplantation], Rev Prat Dec, vol.1558, pp.2111-2133, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00484234

K. Peggs, Reconstitution of adaptive and innate immunity following allogeneic hematopoietic stem cell transplantation in humans, Cytotherapy, vol.8, issue.5, pp.427-463, 2006.
DOI : 10.1080/14653240600851938

N. Dulphy, P. Haas, and M. Busson, An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation, J Immunol Blood, vol.181101, issue.39, pp.2227-373730, 2003.

D. Fearnley, L. Whyte, S. Carnoutsos, A. Cook, and D. Hart, Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation, Blood, vol.93, issue.2, pp.728-764, 1999.

K. Peggs and S. Mackinnon, Immune reconstitution following haematopoietic stem cell transplantation, British Journal of Haematology, vol.95, issue.4, pp.407-427, 2004.
DOI : 10.1182/blood.V97.5.1458

URL : http://onlinelibrary.wiley.com/doi/10.1046/j.1365-2141.2003.04767.x/pdf

D. Avigan, L. Pirofski, and H. Lazarus, Vaccination against infectious disease following hematopoietic stem cell transplantation, Biology of Blood and Marrow Transplantation, vol.7, issue.3, pp.171-83, 2001.
DOI : 10.1053/bbmt.2001.v7.pm11302551

URL : https://doi.org/10.1053/bbmt.2001.v7.pm11302551

J. Malfuson, Y. Hicheri, and P. Bonin, Incompatibilit?? ABO et greffe allog??nique de cellules souches h??matopo????tiques ?? l?????re des conditionnements non my??loablatifs, Transfusion Clinique et Biologique, vol.14, issue.3, pp.327-360, 2007.
DOI : 10.1016/j.tracli.2007.03.002

J. Malfuson, R. Amor, and P. Bonin, Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation, Vox Sanguinis, vol.96, issue.1, pp.85-94, 2007.
DOI : 10.1111/j.1537-2995.2004.04106.x

V. Ratanatharathorn, L. Ayash, and C. Reynolds, Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody, Biology of Blood and Marrow Transplantation, vol.9, issue.8, pp.505-516, 2003.
DOI : 10.1016/S1083-8791(03)00216-7

J. Storek, M. Dawson, and D. Maloney, Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation, Biology of Blood and Marrow Transplantation, vol.9, issue.12, pp.781-785, 2003.
DOI : 10.1016/j.bbmt.2003.09.003

E. Hochberg, A. Chillemi, and C. Wu, Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults, Blood, vol.98, issue.4, pp.1116-1137, 2001.
DOI : 10.1182/blood.V98.4.1116

S. Lewin, G. Heller, and L. Zhang, Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations, Blood, vol.100, issue.6, pp.2235-2277, 2002.

K. Rezvani, S. Mielke, and M. Ahmadzadeh, High donor FOXP3-positive regulatory Tcell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT Immune reconstitution is preserved in hematopoietic stem cell transplant co-administered with regulatory T cells for GVHD prevention Protective conditioning for acute graft-versushost disease, Blood Blood N Engl J Med, vol.108353, issue.413, pp.1291-71321, 2005.

J. Storek, A. Joseph, and G. Espino, Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation, Blood, vol.98, issue.13, pp.3505-3517, 2001.
DOI : 10.1182/blood.V98.13.3505

E. Morris, K. Macdonald, G. F. Hill, N. Schaaf-lafontaine, and S. Humblet-baron, Stem cell mobilization with G-CSF analogs: a rational approach to separate GVHD and GVL? Blood T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation, Transplantation, vol.10776, issue.6012, pp.3430-51705, 2003.

R. Chakraverty, K. Peggs, and R. Chopra, Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen, Blood, vol.99, issue.3, pp.1071-1079, 2002.
DOI : 10.1182/blood.V99.3.1071

S. Chakrabarti, S. Mackinnon, and R. Chopra, High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution, Blood, vol.99, issue.12, pp.4357-63, 2002.
DOI : 10.1182/blood.V99.12.4357

F. Baron, J. Baker, and R. Storb, Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning, Blood, vol.104, issue.8, pp.2254-62, 2004.
DOI : 10.1182/blood-2004-04-1506

K. Williams, F. Hakim, and R. Gress, T cell immune reconstitution following lymphodepletion, Seminars in Immunology, vol.19, issue.5, pp.318-348, 2007.
DOI : 10.1016/j.smim.2007.10.004

URL : http://europepmc.org/articles/pmc2180244?pdf=render

P. Patah, S. Parmar, and J. Mcmannis, Microbial contamination of hematopoietic progenitor cell products: clinical outcome, Bone Marrow Transplantation, vol.15, issue.4, 2007.
DOI : 10.1038/sj.bmt.1705731

O. Landgren, E. Gilbert, and J. Rizzo, Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation, Blood, vol.113, issue.20, pp.4992-5001, 2009.
DOI : 10.1182/blood-2008-09-178046

S. Ocheni, N. Kroeger, and T. Zabelina, EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT, Bone Marrow Transplantation, vol.330, issue.3, 2008.
DOI : 10.1038/bmt.2008.150

URL : http://www.nature.com/bmt/journal/v42/n3/pdf/bmt2008150a.pdf

T. Mori and J. Kato, Cytomegalovirus infection/disease after hematopoietic stem cell transplantation, International Journal of Hematology, vol.101, issue.4, pp.588-95, 2010.
DOI : 10.7326/0003-4819-109-10-783

G. Alangaden, M. Wahiduzzaman, and P. Chandrasekar, Aspergillosis: The Most Common Community???Acquired Pneumonia with Gram???Negative Bacilli as Copathogens in Stem Cell Transplant Recipients with Graft???versus???Host Disease, Clinical Infectious Diseases, vol.15, issue.6, pp.659-64, 2002.
DOI : 10.1086/318133

J. Storek, T. Gooley, R. Witherspoon, K. Sullivan, and R. Storb, Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts, American Journal of Hematology, vol.333, issue.2, pp.131-139, 1997.
DOI : 10.1056/NEJM199509283331305

B. Chung, L. Barbara-burnham, L. Barsky, and K. Weinberg, Radiosensitivity of thymic interleukin-7 production and thymopoiesis after bone marrow transplantation, Blood, vol.98, issue.5, pp.1601-1607, 2001.
DOI : 10.1182/blood.V98.5.1601

C. Sportes, F. Hakim, and S. Memon, Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets, The Journal of Experimental Medicine, vol.153, issue.7, pp.1701-1715, 2008.
DOI : 10.1016/0198-8859(96)00076-6

E. Wils and J. Cornelissen, Thymopoiesis following allogeneic stem cell transplantation: new possibilities for improvement, Blood Reviews, vol.19, issue.2, pp.89-98, 2005.
DOI : 10.1016/j.blre.2004.04.001

W. Krenger and G. Hollander, The immunopathology of thymic GVHD, Seminars in Immunopathology, vol.105, issue.Suppl 1, pp.439-56, 2008.
DOI : 10.4049/jimmunol.175.4.2741

D. Douek, R. Vescio, and M. Betts, Assessment of thymic output in adults after haematopoietic stemcell transplantation and prediction of T-cell reconstitution, The Lancet, vol.355, issue.9218, pp.1875-81, 2000.
DOI : 10.1016/S0140-6736(00)02293-5

K. Schluns, W. Kieper, S. Jameson, and L. Lefrancois, Interleukin-7 mediates the homeostasis of na??ve and memory CD8 T cells in vivo, Nature Immunology, vol.90, issue.5, 2000.
DOI : 10.1073/pnas.90.19.9125

S. Solomon, S. Mielke, and B. Savani, Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation, Blood, vol.106, issue.3, pp.1123-1132, 2005.
DOI : 10.1182/blood-2005-01-0393

K. Peggs, Immune Reconstitution following Stem Cell Transplantation, Leukemia & Lymphoma, vol.360, issue.6, pp.1093-101, 2004.
DOI : 10.1172/JCI17601

X. Chen, R. Barfield, and E. Benaim, Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients Clinical implications of T cell receptor repertoire analysis after allogeneic stem cell transplantation, Blood Hematology, vol.105, issue.80, pp.886-93, 2004.

S. Weller, M. Braun, and B. Tan, Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire Molecular TCR diagnostics can be used to identify shared clonotypes after allogeneic hematopoietic stem cell transplantation, Blood Exp Hematol, vol.10432, issue.8210, pp.3647-541010, 2004.

A. Gratwohl, J. Hermans, and J. Apperley, Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation, Blood, 1995.

S. Lee, G. Vogelsang, and A. Gilman, A survey of diagnosis, management, and grading of chronic GVHD, Biology of Blood and Marrow Transplantation, vol.8, issue.1, pp.32-41, 2002.
DOI : 10.1053/bbmt.2002.v8.pm11846354

L. Rebellato, U. Gross, K. Verbanac, and J. Thomas, A COMPREHENSIVE DEFINITION OF THE MAJOR ANTIBODY SPECIFICITIES IN POLYCLONAL RABBIT ANTITHYMOCYTE GLOBULIN1, Transplantation, vol.57, issue.5, pp.685-94, 1994.
DOI : 10.1097/00007890-199403150-00010

G. Souillet, S. Rey, and Y. Bertrand, Outcome of unrelated bone marrow donor searches in 174 children resulting in 45 patients transplanted in the HLA-matched and -mismatched situation, Bone Marrow Transplantation, vol.86, issue.1, pp.31-43, 2000.
DOI : 10.1097/00007890-199809150-00013

N. Bonnefoy-berard and J. Revillard, Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3, J Heart Lung Transplant, vol.15, issue.5, pp.435-477, 1996.

N. Bonnefoy-berard, C. Vincent, and J. Revillard, ANTIBODIES AGAINST FUNCTIONAL LEUKOCYTE SURFACE MOLECULES IN POLYCLONAL ANTILYMPHOCYTE AND ANTITHYMOCYTE GLOBULINS, TRANSPLANTATION, vol.51, issue.3, pp.669-73, 1991.
DOI : 10.1097/00007890-199103000-00024

L. Fang, B. Fehse, M. Engel, A. Zander, and N. Kroger, Antithymocyte Globulin Induces Ex Vivo and In Vivo Depletion of Myeloid and Plasmacytoid Dendritic Cells, Transplantation, vol.79, issue.3, pp.369-71, 2005.
DOI : 10.1097/01.TP.0000150210.77543.1B

M. Zand, T. Vo, and J. Huggins, Polyclonal rabbit antithymocyte globulin triggers Bcell and plasma cell apoptosis by multiple pathways, Transplantation Jun, vol.1579, issue.11, pp.1507-1522, 2005.
DOI : 10.1097/01.tp.0000164159.20075.16

URL : http://pdfs.journals.lww.com/transplantjournal/2005/06150/Polyclonal_Rabbit_Antithymocyte_Globulin_Triggers.8.pdf?token=method|ExpireAbsolute;source|Journals;ttl|1505080208689;payload|mY8D3u1TCCsNvP5E421JYK6N6XICDamxByyYpaNzk7FKjTaa1Yz22MivkHZqjGP4kdS2v0J76WGAnHACH69s21Csk0OpQi3YbjEMdSoz2UhVybFqQxA7lKwSUlA502zQZr96TQRwhVlocEp/sJ586aVbcBFlltKNKo+tbuMfL73hiPqJliudqs17cHeLcLbV/CqjlP3IO0jGHlHQtJWcICDdAyGJMnpi6RlbEJaRheGeh5z5uvqz3FLHgPKVXJzdGlb2qsojlvlytk14LkMXSHuoF62fy+5jTG3go+I9W8BHG7by6MKXPmCAznIvBmk1;hash|BfLtGbY7/3wJacwUVUSSng==

F. Ayuk, L. Fang, B. Fehse, A. Zander, and N. Kroger, Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells, Experimental Hematology, vol.33, issue.12, pp.1531-1537, 2005.
DOI : 10.1016/j.exphem.2005.08.004

C. Grullich, C. Ziegler, and J. Finke, Rabbit Anti T-Lymphocyte Globulin Induces Apoptosis in Peripheral Blood Mononuclear Cell Compartments and Leukemia Cells, While Hematopoetic Stem Cells Are Apoptosis Resistant, Biology of Blood and Marrow Transplantation, vol.15, issue.2, 2009.
DOI : 10.1016/j.bbmt.2008.11.014

T. Eiermann, P. Lambrecht, and A. Zander, Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients, Bone Marrow Transplantation, vol.23, issue.8, pp.779-81, 1999.
DOI : 10.1038/sj.bmt.1701645

M. Remberger and B. Sundberg, Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation, Haematologica, vol.90, issue.7, pp.931-939, 2005.

P. Monti, P. Allavena, D. Carlo, V. Piemonti, and L. , Effects of anti-lymphocytes and antithymocytes globulin on human dendritic cells, Int Immunopharmacol, 2003.

F. Ayuk, J. Perez-simon, and A. Shimoni, Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation, Haematologica, vol.93, issue.9, pp.1343-50, 2008.
DOI : 10.3324/haematol.12665

F. Ayuk, A. Zander, and N. Kroger, Antitumor effects of polyclonal antithymocyte globulins: focus on B-cell malignancies and multiple myeloma, Annals of Hematology, vol.103, issue.13, 2009.
DOI : 10.1097/00007890-199504270-00020

URL : https://hal.archives-ouvertes.fr/hal-00535027

D. Bunn, C. Lea, D. Bevan, R. Higgins, and B. Hendry, The pharmacokinetics of antithymocyte globulin (ATG) following intravenous infusion in man, Clin Nephrol, 1996.

E. Waller, A. Langston, and S. Lonial, Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation, Biology of Blood and Marrow Transplantation, vol.9, issue.7, pp.460-71, 2003.
DOI : 10.1016/S1083-8791(03)00127-7

R. Storb, P. Weiden, and K. Sullivan, Second marrow transplants in patients with aplastic anemia rejecting the first graft: use of a conditioning regimen including cyclophosphamide and antithymocyte globulin, Blood, vol.70, issue.1, pp.116-137, 1987.

R. Storb, R. Etzioni, and C. Anasetti, Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia, Blood, vol.84, issue.3, pp.941-950, 1994.

P. Weiden, K. Doney, R. Storb, and E. Thomas, ANTIHUMAN THYMOCYTE GLOBULIN FOR PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE, Transplantation, vol.27, issue.4, pp.227-257, 1979.
DOI : 10.1097/00007890-197904000-00003

M. Remberger, J. Aschan, L. Barkholt, J. Tollemar, and O. Ringden, Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin, Clinical Transplantation, vol.24, issue.6, 2001.
DOI : 10.1097/00007890-200102150-00017

N. Ramsay, J. Kersey, and L. Robison, A Randomized Study of the Prevention of Acute Graft-versus-Host Disease, New England Journal of Medicine, vol.306, issue.7, pp.392-399, 1982.
DOI : 10.1056/NEJM198202183060703

J. Schetelig, M. Bornhauser, and M. Kiehl, Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation ??? a retrospective analysis, Bone Marrow Transplantation, vol.100, issue.5, 2004.
DOI : 10.1038/sj.bmt.1703674

A. Bacigalupo, T. Lamparelli, and P. Bruzzi, Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO), Blood, vol.98, issue.10, pp.2942-2949, 2001.
DOI : 10.1182/blood.V98.10.2942

A. Bacigalupo, T. Lamparelli, and F. Gualandi, Prophylactic antithymocyte globulin reduces the risk of chronic graft-versus-host disease in alternative-donor bone marrow transplants, Biology of Blood and Marrow Transplantation, vol.8, issue.12, pp.656-61, 2002.
DOI : 10.1053/bbmt.2002.v8.abbmt080656

A. Bacigalupo, T. Lamparelli, and G. Barisione, Thymoglobulin Prevents Chronic Graft-versus-Host Disease, Chronic Lung Dysfunction, and Late Transplant-Related Mortality: Long-Term Follow-Up of a Randomized Trial in Patients Undergoing Unrelated Donor Transplantation, Biology of Blood and Marrow Transplantation, vol.12, issue.5, pp.560-565, 2006.
DOI : 10.1016/j.bbmt.2005.12.034

J. Finke, W. Bethge, and C. Schmoor, Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial, The Lancet Oncology, vol.10, issue.9, pp.855-64, 2009.
DOI : 10.1016/S1470-2045(09)70225-6

M. Remberger, B. Storer, O. Ringden, and C. Anasetti, Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors, Bone Marrow Transplantation, vol.24, issue.5, pp.391-398, 2002.
DOI : 10.3109/10428199609045715

URL : http://www.nature.com/bmt/journal/v29/n5/pdf/1703374a.pdf

N. Kroger, T. Zabelina, and W. Kruger, In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors, Bone Marrow Transplantation, vol.94, issue.8, pp.683-692, 2002.
DOI : 10.1038/sj.bmt.1701645

P. Duggan, K. Booth, and A. Chaudhry, Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis, Bone Marrow Transplantation, vol.96, issue.10, pp.681-687, 2002.
DOI : 10.1200/JCO.1997.15.5.1767

H. Deeg, B. Storer, and M. Boeckh, Reduced incidence of acute and chronic graftversus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen, Biol Blood Marrow Transplant, 2006.

J. Finke, C. Schmoor, H. Lang, K. Potthoff, and H. Bertz, Matched and Mismatched Allogeneic Stem-Cell Transplantation From Unrelated Donors Using Combined Graft-Versus-Host Disease Prophylaxis Including Rabbit Anti???T Lymphocyte Globulin, Journal of Clinical Oncology, vol.21, issue.3, pp.506-519, 2003.
DOI : 10.1200/JCO.2003.03.129

F. Ayuk, G. Diyachenko, and T. Zabelina, Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors, Experimental Hematology, vol.36, issue.8, pp.1047-54, 2008.
DOI : 10.1016/j.exphem.2008.03.011

N. Kroger, T. Zabelina, and T. Binder, HLA-Mismatched Unrelated Donors as an Alternative Graft Source for Allogeneic Stem Cell Transplantation after Antithymocyte Globulin-Containing Conditioning Regimen, Biology of Blood and Marrow Transplantation, vol.15, issue.4, 2009.
DOI : 10.1016/j.bbmt.2009.01.002

E. Meijer, J. Cornelissen, B. Lowenberg, and L. Verdonck, Antithymocyteglobulin as prophylaxis of graft failure and graft-versus-host disease in recipients of partially T-cell???depleted grafts from matched unrelated donors: A dose-finding study, Experimental Hematology, vol.31, issue.11, pp.1026-1056, 2003.
DOI : 10.1016/S0301-472X(03)00204-2

F. Ayuk, G. Diyachenko, and T. Zabelina, Comparison of Two Doses of Antithymocyte Globulin in Patients Undergoing Matched Unrelated Donor Allogeneic Stem Cell Transplantation, Biology of Blood and Marrow Transplantation, vol.14, issue.8, pp.913-922, 2008.
DOI : 10.1016/j.bbmt.2008.05.023

M. Schleuning, W. Gunther, J. Tischer, G. Ledderose, and H. Kolb, Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML, Bone Marrow Transplantation, vol.22, issue.Suppl. 1, pp.243-50, 2003.
DOI : 10.1182/blood-2002-03-0701

F. Aversa, A. Terenzi, and R. Felicini, Mismatched T cell-depleted hematopoietic stem cell transplantation for children with high-risk acute leukemia, Bone Marrow Transplant, vol.22, issue.5, pp.29-32, 1998.

E. Meijer, A. Bloem, A. Dekker, and L. Verdonck, Effect of antithymocyte globulin on quantitative immune recovery and graft-versus-host disease after partially T-cell???depleted bone marrow transplantation: a comparison between recipients of matched related and matched unrelated donor grafts, Transplantation, vol.75, issue.11, pp.1910-1913, 2003.
DOI : 10.1097/01.TP.0000065737.60591.9D

T. Saito, Y. Kanda, and K. Nakai, Immune reconstitution following reduced-intensity transplantation with cladribine, busulfan and antithymocyte globulin: serial comparison with conventional myeloablative transplantation, Bone Marrow Transplantation, vol.48, issue.6, 2003.
DOI : 10.1111/j.1600-065X.1989.tb00544.x

M. Duval, B. Pedron, and P. Rohrlich, Immune reconstitution after haematopoietic transplantation with two different doses of pre-graft antithymocyte globulin, Bone Marrow Transplantation, vol.73, issue.7, pp.421-427, 2002.
DOI : 10.1016/S1083-8791(00)70007-3

N. Fehse, B. Fehse, and N. Kroger, Influence of Anti-Thymocyte Globulin As Part of the Conditioning Regimen on Immune Reconstitution Following Matched Related Bone Marrow Transplantation, Journal of Hematotherapy & Stem Cell Research, vol.12, issue.2, pp.237-279, 2003.
DOI : 10.1089/152581603321628377

K. Nakai, Y. Kanda, and S. Mineishi, Suspected delayed immune recovery against cytomegalovirus after reduced-intensity stem cell transplantation using anti-thymocyte globulin, Bone Marrow Transplantation, vol.26, issue.3, pp.237-278, 2002.
DOI : 10.1038/sj.bmt.1702500

URL : http://www.nature.com/bmt/journal/v29/n3/pdf/1703351a.pdf

M. Pistillo, P. Tazzari, and F. Bonifazi, Detection of a novel specificity (CTLA-4) in ATG/TMG globulins and sera from ATG-treated leukemic patients1, Transplantation, vol.73, issue.8, pp.1295-302, 2002.
DOI : 10.1097/00007890-200204270-00019

J. Hansen, R. Clift, E. Thomas, C. Buckner, R. Storb et al., Transplantation of Marrow from an Unrelated Donor to a Patient with Acute Leukemia, New England Journal of Medicine, vol.303, issue.10, pp.565-572, 1980.
DOI : 10.1056/NEJM198009043031007

J. Hows, B. Bradley, S. Gore, T. Downie, M. Howard et al., Prospective evaluation of unrelated donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study, Bone Marrow Transplant, 1993.

A. Nademanee, G. Schmidt, and P. Parker, The outcome of matched unrelated donor bone marrow transplantation in patients with hematologic malignancies using molecular typing for donor selection and graft-versus-host disease prophylaxis regimen of cyclosporine, methotrexate, and prednisone, Blood, vol.86, issue.3, pp.1228-1262, 1995.

A. Bacigalupo, Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects, Bone Marrow Transplantation, vol.100, issue.Suppl 1, pp.225-256, 2005.
DOI : 10.1182/blood-2001-12-0304

A. Zander, T. Zabelina, and N. Kroger, Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow, Bone Marrow Transplantation, vol.23, issue.9, 1999.
DOI : 10.1038/sj.bmt.1701745

E. Meijer, A. Dekker, and L. Verdonck, Influence of antithymocyte globulin dose on outcome in cytomegalovirus-seropositive recipients of partially T cell-depleted stem cell grafts from matched-unrelated donors, British Journal of Haematology, vol.153, issue.3, pp.473-479, 2003.
DOI : 10.1038/sj.bmt.1703513

R. Curtis, L. Travis, and P. Rowlings, Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study, Blood, vol.94, issue.7, pp.2208-2224, 1999.

G. Hale and H. Waldmann, Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users, Blood, vol.91, issue.8, pp.3079-83, 1998.

E. Gerritsen, E. Stam, and J. Hermans, Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children, Bone Marrow Transplant, vol.18, issue.2, pp.377-82, 1996.

J. Van-esser, H. Niesters, and B. Van-der-holt, Prevention of Epstein-Barr viruslymphoproliferative disease by molecular monitoring and preemptive rituximab in highrisk patients after allogeneic stem cell transplantation, Blood Jun, vol.1599, issue.12, pp.4364-4373, 2002.

S. Giralt, J. Hester, and Y. Huh, CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation, Blood, vol.86, issue.11, pp.4337-4380, 1995.

P. Weiden, K. Sullivan, N. Flournoy, R. Storb, and E. Thomas, Antileukemic Effect of Chronic Graft-versus-Host Disease, New England Journal of Medicine, vol.304, issue.25, pp.1529-1562, 1981.
DOI : 10.1056/NEJM198106183042507

M. Goerner, T. Gooley, and M. Flowers, Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias, Biology of Blood and Marrow Transplantation, vol.8, issue.1, pp.47-56, 2002.
DOI : 10.1053/bbmt.2002.v8.pm11858190